To include your compound in the COVID-19 Resource Center, submit it here.

Selective kappa opioid receptor agonist could dial out side effects

In a study published in Cell, researchers at the University of North Carolina at Chapel Hill and colleagues solved the crystal structure of the kappa opioid receptor (KOR; OPRK1) bound to

Read the full 317 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers